Funding Rounds
Pulmocide

Pulmocide Unknown (2022, $52M)

Pulmocide

Inhaled medicines developed for treating viral and fungal respiratory infections.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Unknown

Raised Amount: $52.00M